Markets

Market Nav

BALANCE SHEET

You can view the balance sheet for the last 5 years.

Jenburkt Pharmaceuticals Ltd.

May 17 BSE 791.80 (+ 5.30 0.67%)

Volume1432

Prev. Close
786.50

Open Price
778.10

Today's Low / High

778.10 800.00

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

586.90 925.00

Jenburkt Pharmaceuticals Ltd.is not traded in NSE

Standalone

(₹ in Crs.)

Particulars	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	44.13	45.89	45.89	45.89	45.89

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	4.41	4.59	4.59	4.59	4.59
Total Share Capital	4.41	4.59	4.59	4.59	4.59

Reserves and Surplus	117.98	112.79	93.88	75.41	72.88
Total Reserves and Surplus	117.98	112.79	93.88	75.41	72.88
Total Shareholders Funds	122.39	117.38	98.47	80.00	77.47

NON-CURRENT LIABILITIES
Deferred Tax Liabilities [Net]	0.72	0.86	0.08	0.00	0.00
Other Long Term Liabilities	2.94	3.43	3.90	4.26	2.74
Total Non-Current Liabilities	3.66	4.29	3.99	4.26	2.74

CURRENT LIABILITIES
Short Term Borrowings	2.44	5.82	3.71	3.44	7.47
Trade Payables	6.10	7.11	3.61	5.23	6.55
Other Current Liabilities	6.97	8.09	9.33	8.96	8.18
Short Term Provisions	0.26	0.26	1.27	2.17	0.42
Total Current Liabilities	15.76	21.28	17.93	19.80	22.62

Total Capital And Liabilities	141.81	142.95	120.38	104.07	102.82

ASSETS
NON-CURRENT ASSETS
Tangible Assets	10.26	11.09	10.07	8.90	9.43
Intangible Assets	0.19	0.31	0.48	0.84	0.16
Capital Work-In-Progress	0.96	0.21	0.38	0.12	0.99
Other Assets	0.00	0.00	0.00	1.99	0.00
Fixed Assets	11.41	11.61	10.93	11.85	10.58
Non-Current Investments	11.18	7.96	6.50	2.50	1.86
Deferred Tax Assets [Net]	0.42	0.37	0.00	-0.24	0.37
Long Term Loans And Advances	0.06	0.13	0.08	0.07	0.17
Other Non-Current Assets	37.65	46.97	22.95	0.35	0.18
Total Non-Current Assets	60.72	67.05	40.46	14.53	13.16


CURRENT ASSETS
Current Investments	0.00	0.00	0.25	1.57	3.52
Inventories	8.34	9.89	7.58	10.90	9.83
Trade Receivables	16.96	15.21	14.00	17.83	22.89
Cash And Cash Equivalents	53.81	49.02	56.51	57.69	51.70
Short Term Loans And Advances	0.12	0.19	0.11	0.22	0.32
OtherCurrentAssets	1.86	1.60	1.47	1.33	1.40
Total Current Assets	81.09	75.90	79.92	89.54	89.67

Total Assets	141.81	142.95	120.38	104.07	102.82

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	19.55	16.61	16.48	16.61	16.58

NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	11.18	7.96	3.93	2.50	1.86

CURRENT INVESTMENTS
Current Investments Unquoted Book Value	0.00	0.00	0.25	1.57	3.52

Particulars	Mar 23
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00
No. of Equity Shares (in Lacs)	44.13

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	4.41
Total Share Capital	4.41
Reserves and Surplus	117.98
Total Reserves and Surplus	117.98
Total Shareholders Funds	122.39
NON-CURRENT LIABILITIES
Deferred Tax Liabilities [Net]	0.72
Other Long Term Liabilities	2.94
Total Non-Current Liabilities	3.66
CURRENT LIABILITIES
Short Term Borrowings	2.44
Trade Payables	6.10
Other Current Liabilities	6.97
Short Term Provisions	0.26
Total Current Liabilities	15.76
Total Capital And Liabilities	141.81
ASSETS
NON-CURRENT ASSETS
Tangible Assets	10.26
Intangible Assets	0.19
Capital Work-In-Progress	0.96
Other Assets	0.00
Fixed Assets	11.41
Non-Current Investments	11.18
Deferred Tax Assets [Net]	0.42
Long Term Loans And Advances	0.06
Other Non-Current Assets	37.65
Total Non-Current Assets	60.72
CURRENT ASSETS
Current Investments	0.00
Inventories	8.34
Trade Receivables	16.96
Cash And Cash Equivalents	53.81
Short Term Loans And Advances	0.12
OtherCurrentAssets	1.86
Total Current Assets	81.09
Total Assets	141.81
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	19.55
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	11.18
CURRENT INVESTMENTS
Current Investments Unquoted Book Value	0.00